Search Results
Feb 19, 2026, 02:00 ET A World-First in Neonatal Care: Japan Approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as a Prescription Drug for Vulnerable Infants
estimated number of premature infants fed Prolacta's products from January 2007 to May 2025. Ozturk G, Paviani B, Rai R, et al. Investigating milk fat globule structure, size, and functionality after thermal processing and homogenization of human milk. Foods. 2024;13(8):1242. doi:10.3390/foods13081242 Liang
More news about: Prolacta Bioscience
Feb 19, 2026, 02:00 ET A World-First in Neonatal Care: Japan Approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as a Prescription Drug for Vulnerable Infants
estimated number of premature infants fed Prolacta's products from January 2007 to May 2025. Ozturk G, Paviani B, Rai R, et al. Investigating milk fat globule structure, size, and functionality after thermal processing and homogenization of human milk. Foods. 2024;13(8):1242. doi:10.3390/foods13081242 Liang
More news about: Prolacta Bioscience
Feb 19, 2026, 00:00 ET A World-First in Neonatal Care: Japan Approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as a Prescription Drug for Vulnerable Infants
estimated number of premature infants fed Prolacta's products from January 2007 to May 2025. Ozturk G, Paviani B, Rai R, et al. Investigating milk fat globule structure, size, and functionality after thermal processing and homogenization of human milk. Foods. 2024;13(8):1242. doi:10.3390/foods13081242 Liang
More news about: Prolacta Bioscience
Feb 18, 2026, 16:11 ET Wawa Recalls 16-ounce Sized Beverages of Wawa Dutch Chocolate Milk, Wawa Chocolate Milk, Wawa Cookies N Cream Milk, Wawa 2% Reduced Fat Milk at Limited Number of Wawa stores located in PA, NJ, DE and MD due to a Potential Safety Hazard
pieces, which could pose a risk of choking, in 16-ounce Wawa Dutch Chocolate Milk, Wawa Chocolate Milk, Wawa Cookies N Cream Milk and Wawa 2% Reduced Fat Milk.
More news about: Wawa, Inc.
Feb 18, 2026, 13:15 ET InventHelp Inventor Develops All-Organic Fat Burning Formula (NJR-276)
PITTSBURGH, Feb. 18, 2026 /PRNewswire/ -- "I wanted to create an all-organic formula that would be used to burn fat," said an inventor, from Plainfield, N.J., "so I invented the CHRISSY TUMMY BURN. My formula could help people lose weight in difficult areas of the body,
More news about: InventHelp
Feb 18, 2026, 11:05 ET New Research Suggests Red Raspberries May Support Blood Sugar Control and Cognitive Function
health. To better understand this connection, researchers tested whether adding 25 g of freeze-dried red raspberry powder to a high-carbohydrate, moderate-fat meal could influence post-meal metabolic responses and cognitive performance in adults ages 55 to 70 who are overweight or obese.After eating
More news about: Washington Red Raspberry Commission
Feb 18, 2026, 10:56 ET Instant Noodles Market Surges to USD 48.5 Billion by 2033, Propelled by 6.5% CAGR - Verified Market Reports®
significantly across regions, with some governments implementing proactive measures addressing public health concerns. Sodium reduction mandates, trans-fat elimination requirements, and nutritional labeling standards influence product development priorities and market entry strategies. Manufacturers navigate
More news about: Verified Market Reports
Feb 18, 2026, 09:03 ET A World-First in Neonatal Care: Japan Approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as a Prescription Drug for Vulnerable Infants
estimated number of premature infants fed Prolacta's products from January 2007 to May 2025. Ozturk G, Paviani B, Rai R, et al. Investigating milk fat globule structure, size, and functionality after thermal processing and homogenization of human milk. Foods. 2024;13(8):1242. doi:10.3390/foods13081242 Liang
More news about: Prolacta Bioscience
Feb 17, 2026, 12:33 ET Coast Packing Company Announces Winners of 9th Annual #LardLovers Recipe Contest
Coast Packing Company, the leading supplier of animal fat shortenings in the Western United States, today announced the winners of its 9th Annual #LardLovers Recipe Contest. The competition invited home
More news about: Coast Packing Company
Feb 17, 2026, 09:02 ET Advanced Deep Plane Facelift Center of Excellence Established by Dr. Benjamin Stong in Atlanta
dragging effect on the lower eyelid, increasing the vertical height of the lower eyelid, hollowing out the border around the lower eyelid, and accentuating fat pseudoherniation, commonly referred to as under-eye bags. Repositioning the midface with advanced deep plane facelift techniques can often reduce and
More news about: Kalos Facial Plastic Surgery, LLC
Feb 17, 2026, 09:00 ET Function and Erewhon Challenge the Meaning of "Healthy" with "The World's Healthiest Smoothie?"
optimal range for fasting insulin, often linked to eating patterns, while 54 percent show elevated Apolipoprotein B (ApoB), influenced in part by dietary fat quality.The result is a smoothie designed to function as a complete meal — one that fits into real life. It's made with unsweetened almond milk,
More news about: Function Health
Feb 17, 2026, 08:59 ET JYM Supplement Science Launches Creatine+, Its First-Ever Standalone Creatine Formula
mixed as a powder or in capsule form. The results are what you see in the mirror, feel in the gym, and experience in everyday life: more muscle, less fat, greater strength, and improved health, confidence, and performance. The science behind every JYM product is based on decades of research by Dr. Jim
More news about: JYM Supplement Science
Feb 17, 2026, 08:39 ET Vampire Wing Lift® Addresses "Ozempic Vulva": Weight Loss Drugs Spotlight a 16-Year-Old Solution
popularity, a new term has entered public discussion: "Ozempic vulva," referring to the volume loss, laxity, dryness, and discomfort that can follow rapid fat reduction in the vulvar tissues. According to Dr. Charles Runels, MD, President of the Cellular Medicine Association (CMA) and inventor of the
More news about: Cellular Medicine Association
Feb 17, 2026, 07:00 ET CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments
expanding use of GLP-1 therapies for metabolic health and weight management has created a growing population experiencing loss of facial fat, skin laxity, and structural deflation - commonly referred to in the medical community as weight-loss-related facial volume depletion.CollPlant's
More news about: CollPlant
Feb 16, 2026, 08:53 ET Chiquita Brings Everyday Joy to Life in Third Year of Pop by Nature Creative Collaboration with Artist Jiaqi Wang
farming, biodiversity and giving back to the communities in which the banana plantations operate. Great-tasting and convenient Chiquita bananas are fat-free, and provide a source of potassium, fiber and vitamin B6. To learn more, visit
More news about: Chiquita Brands International, Inc.
Feb 13, 2026, 23:48 ET 2026 Toy of the Year® Winners Shine at Toy Industry's Biggest Night
Play Tab (Fat Brain Toy Co.): Infant/Toddler Toy of the Year
More news about: The Toy Foundation
Feb 13, 2026, 15:00 ET Sphingolipids Market Forecast 2025-2035: Global Value to Reach USD 1,145.6 Million by 2035 at 5.1% CAGR
demand. Adoption is also supported by its use in infant nutrition formulations, where bio-functional lipids are leveraged to better reflect the fat profile benefits associated with human milk composition.2) Application Leader: Liposome Drug Delivery Systems (42.8% Share in 2025)LDDS
More news about: Future Market Insights
Feb 13, 2026, 10:01 ET Insect-Based Pet Food Market Forecast 2025-2035: Global Value to Reach USD 4,150.2 Million by 2035 at 10.0% CAGR
immunity.Black Soldier Fly Larvae (BSFL): Increasing adoption due to circular economy alignment—converting organic waste into protein—plus fat composition supportive of skin/coat health and overall wellness.Competitive LandscapeThe market is expanding as consumers
More news about: Future Market Insights
Feb 13, 2026, 08:58 ET Intensity Therapeutics Announces Reverse Stock Split
biotechnology company whose novel engineered chemistry enables aqueous cytotoxic-containing drug formulations to mix and saturate a tumor's dense, high-fat, pressurized environment following direct intratumoral injection. As a result of the saturation, Intensity's clinical trials have demonstrated the
More news about: Intensity Therapeutics Inc.
Feb 13, 2026, 04:01 ET North America Leads the Modified Starch Market with 34% Revenue in 2025 as Global Market Size Set to Surpass 19.90B by 2031 says a 2026 Mordor Intelligence Report
replicate the fibrous texture of muscle tissue in meat analogs. In the dairy sector, these ingredients serve as critical stabilizers that allow for fat reduction without compromising creaminess, helping brands navigate fluctuating input costs. By offering tailored solutions for complex gelling and water-binding
More news about: Mordor Intelligence Private Limited
Feb 12, 2026, 16:43 ET Diamond Lake Clinic Offering Pioneering EXOMIND, Brain Stimulation Device to Treat Depression and Enhance Mental Health
treatment twice a week for three weeks. Research shows patients experience reduced food cravings, and many report weight loss after treatment.For fat reduction, muscle growth and recovery from injury or surgery, the clinic offers
More news about: Diamond Lake Clinic
Feb 12, 2026, 09:00 ET Devonian reports additional molecular data from MASH liver study
NAFLD/MASH1,2Nonalcoholic fatty liver disease (NAFLD) is the most common form of chronic liver disease with a worldwide prevalence of 20-30%. It is represented by fat accumulation in the liver, a condition that is commonly associated with features of the metabolic syndrome (MetS), such as obesity, type 2 diabetes,
More news about: Devonian Health Group Inc.
Feb 12, 2026, 08:47 ET Chiquita Energizes the 2026 Life Time Miami Marathon with Nutrition, Flavor and Global Reach
farming, biodiversity and giving back to the communities in which the banana plantations operate. Great-tasting and convenient Chiquita bananas are fat-free, and provide a source of potassium, fiber and vitamin B6. To learn more, visit
More news about: Chiquita Brands International, Inc.
Feb 12, 2026, 07:30 ET Karyopharm Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress
deaths in 2022.2 Both incidence and mortality have continued to rise.3,4 Key risk factors include obesity, type 2 diabetes, high-fat diets, tamoxifen or oral estrogen use, and delayed menopause.5 TP53 is a well-recognized prognostic marker for EC; >50% of advanced
More news about: Karyopharm Therapeutics Inc.
Feb 11, 2026, 16:16 ET Viking Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update
non-alcoholic fatty liver disease (NAFLD) and elevated LDL-C, patients who received VK2809 demonstrated statistically significant reductions in LDL-C and liver fat content compared with patients who received placebo. The company's newest program is evaluating a series of internally developed dual amylin and calcitonin
More news about: Viking Therapeutics, Inc.